HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

MDL 100907

blocks 3,4-methylenedioxymethamphetamine (MDMA)-stimulated dopamine synthesis in vivo without affecting basal synthesis
Also Known As:
M100907; MDL 100,907; MDL 100105; MDL-100,907; MDL-100907; MDL100105; alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol
Networked: 29 relevant articles (3 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ullrich, Thomas: 3 articles (05/2006 - 05/2004)
2. Rice, Kenner C: 3 articles (05/2006 - 05/2004)
3. Slifstein, Mark: 2 articles (12/2011 - 11/2011)
4. Xu, Xiaoyan: 2 articles (12/2011 - 11/2011)
5. Abi-Dargham, Anissa: 2 articles (12/2011 - 11/2011)
6. Ohara, Shinya: 1 article (03/2015)
7. Tsutsui, Ken-Ichiro: 1 article (03/2015)
8. Ishii, Hironori: 1 article (03/2015)
9. Tobler, Philippe N: 1 article (03/2015)
10. Iijima, Toshio: 1 article (03/2015)

Related Diseases

1. Schizophrenia (Dementia Praecox)
2. Autistic Disorder (Autism)
3. Phencyclidine Abuse
4. Fever (Fevers)
5. Dyskinesias (Dyskinesia)

Related Drugs and Biologics

1. 5-HT2A Serotonin Receptor (5 HT2A Receptor)
2. Risperidone (Risperdal Consta)
3. Clozapine (Clozaril)
4. Dizocilpine Maleate (Dizocilpine)
5. N-Methyl-3,4-methylenedioxyamphetamine (MDMA)
6. Serotonin 5-HT2 Receptor Antagonists
7. Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)
8. Prazosin (Minipress)
9. Levodopa (L Dopa)
10. nantenine

Related Therapies and Procedures

1. Induced Hyperthermia (Thermotherapy)
2. Induced Hypothermia